Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gautam Mehta

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 18, 2003
Temporal analysis of rat growth plates: cessation of growth with age despite presence of a physisHelmtrud I Roach, Gautam Mehta, Richard O C Oreffo, et al.
The Lancet. Public Health|April 13, 2025
Trends in alcohol-specific deaths in England, 2001-22: an observational studyMelissa Oldham, Sarah Jackson, Jamie Brown, et al.
Journal of Hepatology|August 26, 2014
Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertensionRajeshwar P Mookerjee, Gautam Mehta, Vairappan Balasubramaniyan, et al.
Journal of Hepatology|September 13, 2017
Corrigendum to "Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension" [J Hepatol 62 (2015) 325-331]Rajeshwar P Mookerjee, Gautam Mehta, Vairappan Balasubramaniyan, et al.
Journal of Hepatology|March 25, 2014
Inflammation and portal hypertension - the undiscovered countryGautam Mehta, Thierry Gustot, Rajeshwar P Mookerjee, et al.
Journal of Clinical and Experimental Hepatology|October 11, 2018
A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated CirrhosisGautam Mehta, Sam Rousell, Gary Burgess, et al.
Alimentary Pharmacology & Therapeutics|August 2, 2024
Non-selective beta-blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real-world studyRahul Kumar, Su Lin, Gautam Mehta, et al.
Journal of Hepatology|June 6, 2020
SARS-CoV-2: Is the liver merely a bystander to severe disease?Mansoor N Bangash, Jaimin M Patel, Dhruv Parekh, et al.
Nature Communications|December 14, 2023
Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver diseaseChengyi Ding, Linda Ng Fat, Annie Britton, et al.
Plos One|October 28, 2021
Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort studyNathanael Fillmore, Steven Bell, Ciyue Shen, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 18, 2003
Temporal analysis of rat growth plates: cessation of growth with age despite presence of a physisHelmtrud I Roach, Gautam Mehta, Richard O C Oreffo, et al.
The Lancet. Public Health|April 13, 2025
Trends in alcohol-specific deaths in England, 2001-22: an observational studyMelissa Oldham, Sarah Jackson, Jamie Brown, et al.
Journal of Hepatology|August 26, 2014
Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertensionRajeshwar P Mookerjee, Gautam Mehta, Vairappan Balasubramaniyan, et al.
Journal of Hepatology|September 13, 2017
Corrigendum to "Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension" [J Hepatol 62 (2015) 325-331]Rajeshwar P Mookerjee, Gautam Mehta, Vairappan Balasubramaniyan, et al.
Journal of Hepatology|March 25, 2014
Inflammation and portal hypertension - the undiscovered countryGautam Mehta, Thierry Gustot, Rajeshwar P Mookerjee, et al.
Journal of Clinical and Experimental Hepatology|October 11, 2018
A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated CirrhosisGautam Mehta, Sam Rousell, Gary Burgess, et al.
Alimentary Pharmacology & Therapeutics|August 2, 2024
Non-selective beta-blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real-world studyRahul Kumar, Su Lin, Gautam Mehta, et al.
Journal of Hepatology|June 6, 2020
SARS-CoV-2: Is the liver merely a bystander to severe disease?Mansoor N Bangash, Jaimin M Patel, Dhruv Parekh, et al.
Nature Communications|December 14, 2023
Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver diseaseChengyi Ding, Linda Ng Fat, Annie Britton, et al.
Plos One|October 28, 2021
Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort studyNathanael Fillmore, Steven Bell, Ciyue Shen, et al.
Pageof 7